FMR1 and fragile X syndrome: Following 7 days of 5-aza-dC (1 μM), the overall levels of reactivated FMR1 mRNA in 5-aza-dC-treated FXS neurons were comparable to the levels seen in wild-type neurons prior to 5-aza-dC treatment (Figure 1A,B).